ArticleWorld journal of gastrointestinal endoscopy2025
Initial treatment approaches for nodular gastric antral vascular ectasia: A comparison of endoscopic band ligation and thermal therapies.
Article in World journal of gastrointestinal endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric antral vascular ectasia (GAVE) accounts for up to 4% of nonvariceal upper gastrointestinal bleeding. Argon plasma coagulation and radiofrequency ablation have been primary treatment modalities for patients with linear and punctate subtypes, with a newer trend of utilization of endoscopic band ligation (EBL). This study evaluates the outcomes of patients undergoing treatment for nodular GAVE. We hypothesize that patients treated initially with EBL will achieve higher rates of clinical remission with fewer endoscopic treatments and a shorter treatment interval.
aimTo investigate the effects of EBL as an initial treatment therapy on outcomes associated with nodular GAVE.
methodsA total of 37 patients at a tertiary medical center with nodular GAVE were included in this retrospective study. The study population was divided between those treated initially with EBL (initial EBL) and initial endoscopic thermal therapy. Pre-treatment and post-treatment hemoglobin values, the model for end-stage liver disease scores, hospitalization rates, and other outcomes. Additionally, endoscopic treatment modality type and frequency were recorded, including radiofrequency ablation, argon plasma coagulation, and EBL. Continuous variables were compared using a
resultsLinear regression analysis displayed a positive relationship between the time interval from initial therapeutic esophagogastroduodenoscopy to first EBL treatment and overall treatment interval (
conclusionThe observed trend favoring EBL, combined with its association with improved clinical remission and reduced treatment burden, supports its consideration as a preferred initial treatment approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.